CHM 0.00% 2.0¢ chimeric therapeutics limited

How's the Capital Raise Going to Work?, page-2

  1. 4,331 Posts.
    lightbulb Created with Sketch. 2022
    If the readout of the 3rd cohort shows promise of disease control or better. we may have the 1st CarT drug that can tackle solid tumour cancer.

    That may be the catalyst you are looking for. Remember that the NK trial underway now is of no cost to CHM.

    Luckily CHM is run by a group of highly experienced folk. This is not their first rodeo.With the tiny SOI now, and incredibly low market cap for its pipeline. even with dilution now, thd potential of many multiples of upside is still available.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.000(0.00%)
Mkt cap ! $17.52M
Open High Low Value Volume
2.2¢ 2.2¢ 2.0¢ $7.495K 357.9K

Buyers (Bids)

No. Vol. Price($)
5 374162 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 729299 3
View Market Depth
Last trade - 10.22am 24/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.